Fluticasone furoate/vilanterol (trade name Breo Ellipta in the US and Relvar Ellipta in Europe) is a combination drug for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is contains fluticasone furoate a corticosteroid and vilanterol a long acting β2-agonist.
This page contains content from the copyrighted Wikipedia article "Fluticasone furoate/vilanterol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.